Cost-Effectiveness of Disease-Modifying Therapies for the Treatment of Patients with Highly Active Multiple Sclerosis - Swedish Perspective (P06.199)
2012 ◽
Vol 78
(Meeting Abstracts 1)
◽
pp. P06.199-P06.199
2015 ◽
Vol 86
(11)
◽
pp. e4.28-e4
2008 ◽
Vol 26
(7)
◽
pp. 617-627
◽
2020 ◽
Vol 12
(5)
◽
pp. 138-145
2019 ◽
Vol 15
(5)
◽
pp. 216-222
2019 ◽
Vol 30
◽
pp. 215-224
◽
2020 ◽
Vol 27
(1)
◽
pp. 151-154
◽
2019 ◽
Vol 119
(10)
◽
pp. 49
◽
2016 ◽
Vol 20
(3)
◽
pp. 297-302
◽
2012 ◽
Vol 12
(5)
◽
pp. 592-600
◽
Keyword(s):
2020 ◽
Vol 12
(3)
◽
pp. 93-99
◽